Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
PubPharm (60.420)
101
SAR408701 versus docetaxel in previously treated, Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) positive metastatic non-squamous non-small cell lung cancer patients : Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel in Previously Treated metastatic Non-Squamous Non-Small Cell Lung Cancer patients with CEACAM5 positive tumors - CARMEN-LC03
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
102
A Study of Benralizumab in Patients with Eosinophilic Esophagitis : A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis (MESSINA) - MESSINA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
103
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple Myeloma : A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
104
To Assess the Efficacy and Safety of ANB019 in Subjects with Generalized Pustular Psoriasis : A Single Arm Multiple Dose Study to Assess the Efficacy and Safety of ANB019 in Subjects with Generalized Pustular Psoriasis - ANB019-002 - Generalized Pustular Psoriasis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
105
Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Study Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck : An Open Label, Randomized, Two Arm Phase III Study of Nivolumab in Combination with Ipilimumab versus Extreme Study Regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as First Line Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) - (CheckMate 651: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 651)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
106
A Study of the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis : A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis - QUASAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
107
Testing a new treatment for patients with heart disease : Low-dose interleukin-2 for the reduction of vascular inflammation in Acute Coronary Syndromes (IVORY) - IVORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
108
Extended Access of Momelotinib for Subjects with Myelofibrosis : Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essentialThrombocythemia Myelofibrosis (Post-PV/ET MF)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
109
Randomized, double blind, safety, efficacy Doravirine/Islatravir in Treatment naïve : A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants - Randomized, double blind, safety, efficacy Doravirine/Islatravir in Tx naïve
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
110
A Clinical Trial for Newly Diagnosed High Risk Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer : A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer(CheckMate 7FL: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 7FL) - Nivo/Placebo with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in ER+/HER2-Breast Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[6042]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
60.420
Aufsätze
60.420
E-Artikel
60.420
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
60.420
610
60.420
Recruitment Status: Authorised-recruitment may ...
60.420
Study Type: Interventional
23.556
Phase: Phase 3
15.068
Phase: Phase 2
4.508
Phase: Phase 4
3.278
Phase: Phase 1
152
Medical Condition: Multiple Myeloma MedDRA vers...
122
Medical Condition: Moderately to Severely Activ...
114
Medical Condition: Diabetes Mellitus, Type 2 Me...
88
Medical Condition: Atopic Dermatitis MedDRA ver...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
84
Medical Condition: Cystic Fibrosis MedDRA versi...
76
Medical Condition: Asthma MedDRA version: 20.0L...
68
Medical Condition: Myelofibrosis MedDRA version...
66
Medical Condition: Mild cognitive impairment (M...
64
Medical Condition: Chronic Obstructive Pulmonar...
64
Medical Condition: Moderately to Severely Activ...
64
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
35.522
2020-
24.898
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
56.722
Englisch
1.244
Unbestimmt
1.058
Französisch
794
Spanisch
162
Finnisch
124
Deutsch
70
Schwedisch
58
Niederländisch
58
Italienisch
44
Dänisch
26
Galizisch
12
Ungarisch
10
Norwegisch
8
Tschechisch
6
Latein
4
Isländisch
2
Estnisch
2
Frisian
2
Hausa
2
Indonesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...